Amgen
One of the largest biotechs — bone, cardiovascular, and cancer biologics.
Coverage of Amgen is holding steady : 3 signals on the latest tracked day, up 50% from its three-week baseline of 2, across 2 domains (down from 3 a week ago). That makes it the #134 most-covered of the 274 concerns we track.
What’s changed
- Does anyone know questions Amgen will as for an Administrative Coordinator role? · Reddit r/biotech · 2026-08-05
- Amgen drops early-stage obesity drug, upping pressure on MariTide · Fierce Biotech · 2026-08-05
- STAT+: Moderna launches early trial of Ebola mRNA vaccine · STAT News — All Content · 2026-08-06
- Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027 · Fierce Biotech · 2026-08-06
- Amgen rides Repatha renaissance as cardio wins keep cholesterol med's momentum rolling · Fierce Pharma · 2026-08-05 · usually covers FDA Decisions
- Amgen says cloud data breach exposed patient health, proprietary info · BleepingComputer · 2026-08-01 · usually covers Cybersecurity
What the reporting says
Across 26 tracked stories from 12 outlets, reporting on Amgen most often describes IPOs or listings (3), regulatory approvals (3), legal rulings (2), price levels (1), acquisition (1), launches or releases (1).
It shows up alongside FDA (10).
Two steps out: AI (through FDA, 10 shared stories on the weaker link); China (through FDA, 10 shared stories on the weaker link); CMS (through FDA, 10 shared stories on the weaker link); Colorectal Cancer (through FDA, 10 shared stories on the weaker link).
Tracked since Jun 21, with coverage on 16 separate days — concentrated in Biotech Pharma and Pharma Pipeline.